Expression level and clinical significance of IL-29 in serum of patients with coronary heart disease

Abstract Background Coronary heart disease (CHD) is a chronic inflammatory disease carrying high morbidity and mortality. Interleukin (IL)-29 may be used as a biomarker for autoimmune diseases. This paper investigates the diagnostic value of serum IL-29 in CHD patients. Methods A total of 90 CHD pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Ping Ni, Liming Dai, Hai Li, Jun Sun, Yicheng Zhu, Xiaolei Lv
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Online Access:https://doi.org/10.1186/s13019-025-03490-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850231054720303104
author Ping Ni
Liming Dai
Hai Li
Jun Sun
Yicheng Zhu
Xiaolei Lv
author_facet Ping Ni
Liming Dai
Hai Li
Jun Sun
Yicheng Zhu
Xiaolei Lv
author_sort Ping Ni
collection DOAJ
description Abstract Background Coronary heart disease (CHD) is a chronic inflammatory disease carrying high morbidity and mortality. Interleukin (IL)-29 may be used as a biomarker for autoimmune diseases. This paper investigates the diagnostic value of serum IL-29 in CHD patients. Methods A total of 90 CHD patients (39 mild and 51 severe patients) and 90 controls were included. Serum IL-29 levels were detected by ELISA, and the diagnostic value of IL-29 in CHD was analyzed by ROC curve. According to the median value of serum IL-29 level, CHD patients were categorized into IL-29 low-level group and high-level group. The correlation between IL-29 and pathological indexes of CHD patients was analyzed by chi-square test. SYNTAX score was used to classify CHD patients into mild CHD and moderate/severe CHD. Pearson coefficient analyzed the correlation between IL-29 and CHD severity. Multivariate logistic regression analyzed the risk factors for CHD exacerbation. Results IL-29 serum levels were elevated in CHD patients. The AUC for CHD diagnosis by serum IL-29 was 0.789 (65.6% sensitivity and 76.7% specificity). IL-29 was correlated with BMI, PHASE score, and CRP. IL-29 serum level was positively correlated with CHD severity. The AUC for differentiating mild and moderate/severe CHD patients by IL-29 level was 0.739 (70.6% sensitivity and 66.7% specificity). IL-29 was an independent risk factor for CHD exacerbation, and each one-unit increase in IL-29 increased the risk of exacerbation in CHD patients by 1.065-fold. Conclusion IL-29 is highly expressed in CHD patients and has auxiliary diagnostic value for CHD.
format Article
id doaj-art-e393b558bc1c43f0a61a3ad7c831ddbe
institution OA Journals
issn 1749-8090
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series Journal of Cardiothoracic Surgery
spelling doaj-art-e393b558bc1c43f0a61a3ad7c831ddbe2025-08-20T02:03:39ZengBMCJournal of Cardiothoracic Surgery1749-80902025-05-012011710.1186/s13019-025-03490-yExpression level and clinical significance of IL-29 in serum of patients with coronary heart diseasePing Ni0Liming Dai1Hai Li2Jun Sun3Yicheng Zhu4Xiaolei Lv5Department of Cardiology, The Third People’s Hospital of KunshanDepartment of Cardiology, The Third People’s Hospital of KunshanDepartment of Cardiology, The Third People’s Hospital of KunshanDepartment of Cardiology, The Third People’s Hospital of KunshanDepartment of Cardiology, The Third People’s Hospital of KunshanDepartment of Cardiology, The First People’s Hospital of KunshanAbstract Background Coronary heart disease (CHD) is a chronic inflammatory disease carrying high morbidity and mortality. Interleukin (IL)-29 may be used as a biomarker for autoimmune diseases. This paper investigates the diagnostic value of serum IL-29 in CHD patients. Methods A total of 90 CHD patients (39 mild and 51 severe patients) and 90 controls were included. Serum IL-29 levels were detected by ELISA, and the diagnostic value of IL-29 in CHD was analyzed by ROC curve. According to the median value of serum IL-29 level, CHD patients were categorized into IL-29 low-level group and high-level group. The correlation between IL-29 and pathological indexes of CHD patients was analyzed by chi-square test. SYNTAX score was used to classify CHD patients into mild CHD and moderate/severe CHD. Pearson coefficient analyzed the correlation between IL-29 and CHD severity. Multivariate logistic regression analyzed the risk factors for CHD exacerbation. Results IL-29 serum levels were elevated in CHD patients. The AUC for CHD diagnosis by serum IL-29 was 0.789 (65.6% sensitivity and 76.7% specificity). IL-29 was correlated with BMI, PHASE score, and CRP. IL-29 serum level was positively correlated with CHD severity. The AUC for differentiating mild and moderate/severe CHD patients by IL-29 level was 0.739 (70.6% sensitivity and 66.7% specificity). IL-29 was an independent risk factor for CHD exacerbation, and each one-unit increase in IL-29 increased the risk of exacerbation in CHD patients by 1.065-fold. Conclusion IL-29 is highly expressed in CHD patients and has auxiliary diagnostic value for CHD.https://doi.org/10.1186/s13019-025-03490-yCoronary heart diseaseIL-29DiagnosisROCLogistic regressionSYNTAX score
spellingShingle Ping Ni
Liming Dai
Hai Li
Jun Sun
Yicheng Zhu
Xiaolei Lv
Expression level and clinical significance of IL-29 in serum of patients with coronary heart disease
Journal of Cardiothoracic Surgery
Coronary heart disease
IL-29
Diagnosis
ROC
Logistic regression
SYNTAX score
title Expression level and clinical significance of IL-29 in serum of patients with coronary heart disease
title_full Expression level and clinical significance of IL-29 in serum of patients with coronary heart disease
title_fullStr Expression level and clinical significance of IL-29 in serum of patients with coronary heart disease
title_full_unstemmed Expression level and clinical significance of IL-29 in serum of patients with coronary heart disease
title_short Expression level and clinical significance of IL-29 in serum of patients with coronary heart disease
title_sort expression level and clinical significance of il 29 in serum of patients with coronary heart disease
topic Coronary heart disease
IL-29
Diagnosis
ROC
Logistic regression
SYNTAX score
url https://doi.org/10.1186/s13019-025-03490-y
work_keys_str_mv AT pingni expressionlevelandclinicalsignificanceofil29inserumofpatientswithcoronaryheartdisease
AT limingdai expressionlevelandclinicalsignificanceofil29inserumofpatientswithcoronaryheartdisease
AT haili expressionlevelandclinicalsignificanceofil29inserumofpatientswithcoronaryheartdisease
AT junsun expressionlevelandclinicalsignificanceofil29inserumofpatientswithcoronaryheartdisease
AT yichengzhu expressionlevelandclinicalsignificanceofil29inserumofpatientswithcoronaryheartdisease
AT xiaoleilv expressionlevelandclinicalsignificanceofil29inserumofpatientswithcoronaryheartdisease